Disodium cromoglycate inhibits capsaicin-induced eosinophil infiltration of conjunctiva independent of mast cells.

Author: EbiharaNobuyuki, MurakamiAkira, NishikawaMotoaki

Paper Details 
Original Abstract of the Article :
PURPOSE: To investigate whether disodium cromoglycate (DSCG) inhibits capsaicin-induced eosinophil infiltration of the conjunctiva independent of mast cells. METHODS: We administered 5 microl of capsaicin solution (10(-5) M) into the conjunctival sacs of mast cell-deficient W/W(v) mice (12 animals)...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10384-005-0314-9

データ提供:米国国立医学図書館(NLM)

Disodium Cromoglycate Inhibits Capsaicin-Induced Eosinophil Infiltration of Conjunctiva

The human eye, like a delicate desert flower, is susceptible to various irritants and inflammatory reactions. This study investigates the role of disodium cromoglycate (DSCG), a drug commonly used to treat allergies, in inhibiting capsaicin-induced eosinophil infiltration of the conjunctiva, the transparent membrane that covers the front of the eye. The researchers conducted experiments using both wild-type mice and mast cell-deficient mice to determine whether DSCG could suppress eosinophil infiltration independent of mast cells, which are immune cells that play a role in allergic reactions. The study found that DSCG effectively inhibited capsaicin-induced eosinophil infiltration, suggesting that it may have therapeutic potential for treating conjunctivitis, an inflammation of the conjunctiva.

DSCG's Anti-Inflammatory Effect in the Conjunctiva

The study's findings suggest that DSCG can directly inhibit neuropeptide-induced eosinophil infiltration of the conjunctiva, independent of mast cells. This implies that DSCG may have a broader anti-inflammatory effect in the conjunctiva, potentially targeting multiple inflammatory pathways. These findings provide further evidence for the potential of DSCG as a treatment for conjunctivitis and other inflammatory eye conditions.

New Avenues for Treating Conjunctivitis and Other Eye Conditions

This study offers promising insights into the potential of DSCG as a treatment for conjunctivitis and other inflammatory eye conditions. The findings suggest that DSCG may be effective in suppressing inflammation and reducing eosinophil infiltration, potentially leading to improved symptom management and faster recovery. Further research is warranted to fully explore the therapeutic potential of DSCG in treating various eye conditions.

Dr. Camel's Conclusion

This study, like a refreshing desert spring, sheds light on the potential of DSCG in treating inflammatory eye conditions. It suggests that DSCG can effectively target multiple inflammatory pathways, offering a promising avenue for developing new and effective treatments for conjunctivitis and other eye conditions. This research is a reminder that even seemingly simple medications can have complex and beneficial effects on the human body.

Date :
  1. Date Completed 2006-07-18
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

16767373

DOI: Digital Object Identifier

10.1007/s10384-005-0314-9

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.